Bicara Therapeutics Inc (BCAX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current BCAX market cap is 993.55M. The company's latest EPS is USD -1.0043 and P/E is -19.11.
| Quarter End | |
|---|---|
| USD ($) | |
| Total Revenue | |
| Operating Income | |
| Net Income |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 0 |
| Operating Income | -39.89M |
| Net Income | -51.99M |
| Quarter End | |
|---|---|
| USD ($) | |
| Total Assets | |
| Total Liabilities | |
| Total Equity |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Assets | 233.98M |
| Total Liabilities | 15.47M |
| Total Equity | -148.77M |
| Market Cap | 993.55M |
| Price to Earnings Ratio | -19.11 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.31 |
| Price to Book Ratio | 4.55 |
| Dividend Yield | - |
| Shares Outstanding | 51.76M |
| Average Volume (1 week) | 300.04k |
| Average Volume (1 Month) | 271.97k |
| 52 Week Change | -26.88% |
| 52 Week High | 27.95 |
| 52 Week Low | 18.33 |
| Spread (Intraday) | 12.3 (40.3%) |
| Company Name | Bicara Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.bicara.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
